top of page

Our Vision is to pioneer definitive therapies that safeguard the economics of healthcare

Medicare's trust fund is projected to be depleted by 2031

Innovation is needed to challenge the status-quo in healthcare

However, we've observed trends in the life science innovation ecosystem that are worrisome...

 

Academia

Historically a source of new innovation, yet due to complex technology transfer practices, all too often discoveries end up in technology graveyards

Start-ups

Inexperienced teams create a high probability for failure in the regulated life sciences industry, inadequate capitalization leads to day to day survival

Venture Capital

Historically a key source of financing for early stage life-sciences companies, now traditional VC firms are pivoting to de-risked growth stage opportunities

Corporates

Historically a powerhouse for IP creation and innovation, no longer a source of transformational innovation after R&D layoffs and focus on earnings

We are revitalizing life sciences innovation by pursuing a Venture Studio model

bottom of page